NCT00644280View on ClinicalTrials.gov

Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery

NATerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions
Glaucoma
Interventions
DRUG

Ranibizumab

intravitreal injection of 0.5 mg ranibizumab 1 week prior to tube insertion and then monthly x 2 more injections

Trial Locations (1)

94143-0730

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER